Efficacy and Safety of Adalimumab in Noninfectious Uveitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background: Patients with noninfectious uveitis (NIU) are at risk of systemic side effects of long-term glucocorticoid therapy and uncontrolled inflammatory complications. In urgent need to identify more aggressive therapies, adalimumab (ADA) may be the right choice. Objectives: To summarize the cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Biao, Li, Haoran, Zhang, Li, Zheng, Yanlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109175/
https://www.ncbi.nlm.nih.gov/pubmed/33981245
http://dx.doi.org/10.3389/fphar.2021.673984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109175/
https://www.ncbi.nlm.nih.gov/pubmed/33981245
http://dx.doi.org/10.3389/fphar.2021.673984

Ejemplares similares